Works matching AU Nicholls, Stephen J.

Results: 238
    1
    2

    Using Codesign to Develop a Health Literacy Intervention to Improve the Accessibility and Acceptability of Cardiac Services: The Equal Hearts Study.

    Published in:
    Health Expectations, 2025, v. 28, n. 3, p. 1, doi. 10.1111/hex.70328
    By:
    • Azar, Denise;
    • Wang, Sofia;
    • Flemming‐Judge, Liz;
    • Shee, Anna Wong;
    • Jessup, Rebecca;
    • Sharma, Laveena;
    • Fukumori, Shihoko;
    • Talevski, Jason;
    • Nicholls, Stephen J.;
    • Harris, James;
    • Alston, Laura;
    • Martin, Catherine;
    • Oqueli, Ernesto;
    • van Gaal, William;
    • Beauchamp, Alison
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Redox biomarkers in cardiovascular medicine.

    Published in:
    European Heart Journal, 2015, v. 36, n. 25, p. 1576, doi. 10.1093/eurheartj/ehv126
    By:
    • Galougahi, Keyvan Karimi;
    • Antoniades, Charalambos;
    • Nicholls, Stephen J.;
    • Channon, Keith M.;
    • Figtree, Gemma A.
    Publication type:
    Article
    24

    The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011.

    Published in:
    European Heart Journal, 2014, v. 35, n. 15, p. 960, doi. 10.1093/eurheartj/ehu107
    By:
    • Ray, Kausik K.;
    • Kastelein, John J. P.;
    • Matthijs Boekholdt, S.;
    • Nicholls, Stephen J.;
    • Khaw, Kay-Tee;
    • Ballantyne, Christie M.;
    • Catapano, Alberico L.;
    • Reiner, Željko;
    • Lüscher, Thomas F.
    Publication type:
    Article
    25
    26

    Factors underlying regression of coronary atheroma with potent statin therapy.

    Published in:
    European Heart Journal, 2013, v. 34, n. 24, p. 1818, doi. 10.1093/eurheartj/eht084
    By:
    • Puri, Rishi;
    • Nissen, Steven E.;
    • Ballantyne, Christie M.;
    • Barter, Phillip J.;
    • Chapman, M. John;
    • Erbel, Raimund;
    • Libby, Peter;
    • Raichlen, Joel S.;
    • St. John, Julie;
    • Wolski, Kathy;
    • Uno, Kiyoko;
    • Kataoka, Yu;
    • Nicholls, Stephen J.
    Publication type:
    Article
    27
    28

    Colchicine exerts anti‐atherosclerotic and ‑plaque‐stabilizing effects targeting foam cell formation.

    Published in:
    FASEB Journal, 2023, v. 37, n. 4, p. 1, doi. 10.1096/fj.202201469R
    By:
    • Schwarz, Nisha;
    • Fernando, Sanuja;
    • Chen, Yung‐Chih;
    • Salagaras, Thalia;
    • Rao, Sushma R.;
    • Liyanage, Sanuri;
    • Williamson, Anna E.;
    • Toledo‐Flores, Deborah;
    • Dimasi, Catherine;
    • Sargeant, Timothy J.;
    • Manavis, Jim;
    • Eddy, Eleanor;
    • Kanellakis, Peter;
    • Thompson, Peter L.;
    • Tan, Joanne T. M.;
    • Snel, Marten F.;
    • Bursill, Christina A.;
    • Nicholls, Stephen J.;
    • Peter, Karlheinz;
    • Psaltis, Peter J.
    Publication type:
    Article
    29

    Eukaryotic elongation factor 2 kinase regulates foam cell formation via translation of CD36.

    Published in:
    FASEB Journal, 2022, v. 36, n. 2, p. 1, doi. 10.1096/fj.202101034R
    By:
    • Fernando, Sanuja;
    • Salagaras, Thalia;
    • Schwarz, Nisha;
    • Sandeman, Lauren;
    • Tan, Joanne T. M.;
    • Xie, Jianling;
    • Zareh, Jonar;
    • Jensen, Kirk;
    • Williamson, Anna;
    • Dimasi, Catherine;
    • Chhay, Pich;
    • Toledo‐Flores, Deborah;
    • Long, Aaron;
    • Manavis, Jim;
    • Worthington, Michael;
    • Fitridge, Robert;
    • Di Bartolo, Belinda A.;
    • Bursill, Christina A.;
    • Nicholls, Stephen J.;
    • Proud, Christopher G.
    Publication type:
    Article
    30
    31

    Relation of insulin treatment for type 2 diabetes to the risk of major adverse cardiovascular events after acute coronary syndrome: an analysis of the BETonMACE randomized clinical trial.

    Published in:
    Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01311-9
    By:
    • Schwartz, Gregory G.;
    • Nicholls, Stephen J.;
    • Toth, Peter P.;
    • Sweeney, Michael;
    • Halliday, Christopher;
    • Johansson, Jan O.;
    • Wong, Norman C. W.;
    • Kulikowski, Ewelina;
    • Kalantar-Zadeh, Kamyar;
    • Ginsberg, Henry N.;
    • Ray, Kausik K.
    Publication type:
    Article
    32

    Managing hypercholesterolaemia.

    Published in:
    Australian Prescriber, 2024, v. 47, n. 1, p. 7, doi. 10.18773/austprescr.2024.006
    By:
    • Nelson, Adam J.;
    • Nicholls, Stephen J.
    Publication type:
    Article
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50

    Obicetrapib exhibits favorable physiochemical and pharmacokinetic properties compared to previous cholesteryl ester transfer protein inhibitors: An integrated summary of results from non‐human primate studies and clinical trials.

    Published in:
    Pharmacology Research & Perspectives, 2024, v. 12, n. 6, p. 1, doi. 10.1002/prp2.70010
    By:
    • Nicholls, Stephen J.;
    • Nelson, Adam J.;
    • Kastelein, John J. P.;
    • Ditmarsch, Marc;
    • Hsieh, Andrew;
    • Johnson, Judith;
    • Curcio, Danielle;
    • Kling, Douglas;
    • Kirkpatrick, Carol F.;
    • Davidson, Michael H.
    Publication type:
    Article